Alpha 2.0
Login Register
» Authors » Miriam Almirall

Miriam Almirall

Explore the profile of Miriam Almirall including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 271
Followers 0
Related Specialties
Rheumatology
Neurology
Public Health
Top 10 Co-Authors
Mayte Serrat
Joan Maymo
Juan V Luciano
Albert Feliu-Soler
Sara Marsal
Maria Pilar Lisbona
Tarek Carlos Salman-Monte
Juan P Sanabria-Mazo
Xavier Borras
Marta Muste
Published In
J Rheumatol
Rheumatol Int
Reumatol Clin
Int J Environ Res Public Health
Rheumatology (Oxford)
Affiliations
Soon will be listed here.
Recent Articles
1.
Immune-inflammatory effects of the multicomponent intervention FIBROWALK in outdoor and online formats for patients with fibromyalgia
Ferres S, Serrat M, Auer W, Royuela-Colomer E, Almirall M, Lizama-Lefno A, et al.
Brain Behav Immun . 2025 Jan; 125:184-197. PMID: 39742894
The multicomponent intervention FIBROWALK integrates pain science education (PSE), therapeutic exercise, cognitive behavioral therapy (CBT), and mindfulness training for treating fibromyalgia (FM). This study investigated the effects of the FIBROWALK...
2.
Psychometric properties of performance based tests in patients with Fibromyalgia: A systematic review
Socorro-Cumplido J, Chaler J, Almirall M, Sanchez-Raya J, Cano M, Roman-Vinas B
J Pain . 2024 Nov; :104749. PMID: 39615810
Fibromyalgia (FM) impacts patients' health status, functioning and quality of life. Accurate diagnosis and effective treatment planning require reliable, valid and responsive measures of these domains. This study aimed to...
3.
Study protocol for a three-arm randomized controlled trial investigating the effectiveness, cost-utility, and physiological effects of a fully self-guided digital Acceptance and Commitment Therapy for Spanish patients with fibromyalgia
Gallego A, Serrat M, Royuela-Colomer E, Sanabria-Mazo J, Borras X, Esteve M, et al.
Digit Health . 2024 Mar; 10:20552076241239177. PMID: 38550263
Objective: Fibromyalgia (FM) is a prevalent pain syndrome with significant healthcare and societal costs. The aim of the SMART-FM-SP study is to determine the effectiveness, cost-utility, and physiological effects in...
4.
Restrictive Diets in Patients with Fibromyalgia: State of the Art
Almirall M, Muste M, Serrat M, Tourino R, Espartal E, Marsal S
Biomedicines . 2024 Mar; 12(3). PMID: 38540241
Around 20-30% of Fibromyalgia patients modify their dietary habits after diagnosis, including avoiding certain food groups such as cereals. In this systematic review, we used the PRISMA guidelines to select...
5.
Implementation of the recommendations for the psychological management of patients with spondyloarthritis and inflammatory bowel disease
Urruticoechea-Arana A, Sanz J, Ginard D, Gonzalez-Lama Y, Juanola X, Almirall M, et al.
Reumatol Clin (Engl Ed) . 2023 Oct; 19(8):423-429. PMID: 37805255
Objective: To assess and improve the level of implementation of the recommendations for the psychological management of patients with spondyloarthritis (SpA) and associated inflammatory bowel disease (IBD). Methods: Qualitative study....
6.
Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: implications for disease-related biomarker discovery
Martin F, Blanco-Suarez M, Zambrano P, Caceres O, Almirall M, Alegre-Martin J, et al.
Front Immunol . 2023 Sep; 14:1253121. PMID: 37744357
Background: There is growing evidence of the significance of gastrointestinal complaints in the impairment of the intestinal mucosal barrier function and inflammation in fibromyalgia (FM) and in myalgic encephalomyelitis/chronic fatigue...
7.
Diagnostic delay is associated with uveitis and inflammatory bowel disease in AS: a study of extra-musculoskeletal manifestations in SpA
Michelena X, Zhao S, Marco-Pascual C, Almirall M, Collantes-Estevez E, Font-Ugalde P, et al.
Rheumatology (Oxford) . 2023 May; 63(2):430-435. PMID: 37184889
Objectives: To examine the prevalence of extra-musculoskeletal manifestations (EMM) and the association between diagnostic delay and their incidence in AS and PsA. Methods: This was a retrospective, cohort study comprising...
8.
The Conners Continuous Performance Test CPT3: Is it a reliable marker to predict neurocognitive dysfunction in Myalgic encephalomyelitis/chronic fatigue syndrome?
Fernandez-Quiros J, Lacasa-Cazcarra M, Alegre-Martin J, Sanmartin-Sentanes R, Almirall M, Launois-Obregon P, et al.
Front Psychol . 2023 Mar; 14:1127193. PMID: 36923151
Introduction: The main objective is to delimit the cognitive dysfunction associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in adult patients by applying the Continuous Performance Test (CPT3). Additionally, provide empirical...
9.
Effectiveness, cost-utility and physiological underpinnings of the FIBROWALK multicomponent therapy in online and outdoor format in individuals with fibromyalgia: Study protocol of a randomized, controlled trial (On&Out study)
Serrat M, Ferres S, Auer W, Almirall M, Lluch E, DAmico F, et al.
Front Physiol . 2022 Dec; 13:1046613. PMID: 36452042
The On&Out study is aimed at assessing the effectiveness, cost-utility and physiological underpinnings of the FIBROWALK multicomponent intervention conducted in two different settings: online (FIBRO-On) or outdoors (FIBRO-Out). Both interventions...
10.
Effectiveness of two video-based multicomponent treatments for fibromyalgia: The added value of cognitive restructuring and mindfulness in a three-arm randomised controlled trial
Serrat M, Albajes K, Navarrete J, Almirall M, Lluch Girbes E, Neblett R, et al.
Behav Res Ther . 2022 Sep; 158:104188. PMID: 36116229
Background/objectives: The aim of this study was to examine the effectiveness of two video-based multicomponent programs (FIBROWALK) and the Multicomponent Physiotherapy Program (MPP) for patients with fibromyalgia (FM) compared to...